Sepsis in the critically ill patient.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016638:Critical Illness; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D008264:Macrophages / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D009751:Nutritional Requirements; D018529:Nutritional Support; D010743:Phospholipids / Q000502:physiology; D012307:Risk Factors; D013312:Stress, Physiological / Q000503:physiopathology; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*
D000900:Anti-Bacterial Agents; D010743:Phospholipids